NM_001165963.4:c.5634G>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 2P and 11B. PM2BP4_ModerateBP6_Very_StrongBP7
The NM_001165963.4(SCN1A):c.5634G>A(p.Glu1878Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.000020   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  6.8e-7   (  0   hom.  ) 
Consequence
 SCN1A
NM_001165963.4 synonymous
NM_001165963.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.121  
Publications
1 publications found 
Genes affected
 SCN1A  (HGNC:10585):  (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015] 
 SCN1A-AS1  (HGNC:54069):  (SCN1A and SCN9A antisense RNA 1)  
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44). 
BP6
Variant 2-165991641-C-T is Benign according to our data. Variant chr2-165991641-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 215799.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=0.121 with no splicing effect.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SCN1A | ENST00000674923.1 | c.5634G>A | p.Glu1878Glu | synonymous_variant | Exon 29 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
| SCN1A | ENST00000303395.9 | c.5634G>A | p.Glu1878Glu | synonymous_variant | Exon 28 of 28 | 5 | ENSP00000303540.4 | |||
| SCN1A | ENST00000375405.7 | c.5601G>A | p.Glu1867Glu | synonymous_variant | Exon 26 of 26 | 5 | ENSP00000364554.3 | |||
| SCN1A | ENST00000409050.2 | c.5550G>A | p.Glu1850Glu | synonymous_variant | Exon 28 of 28 | 5 | ENSP00000386312.1 | 
Frequencies
GnomAD3 genomes  0.0000197  AC: 3AN: 152080Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
3
AN: 
152080
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00000399  AC: 1AN: 250504 AF XY:  0.00   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1
AN: 
250504
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  6.84e-7  AC: 1AN: 1461756Hom.:  0  Cov.: 31 AF XY:  0.00  AC XY: 0AN XY: 727178 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1
AN: 
1461756
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
0
AN XY: 
727178
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33468
American (AMR) 
 AF: 
AC: 
1
AN: 
44694
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26130
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39698
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53420
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1111926
Other (OTH) 
 AF: 
AC: 
0
AN: 
60394
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.475 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000197  AC: 3AN: 152080Hom.:  0  Cov.: 32 AF XY:  0.0000269  AC XY: 2AN XY: 74284 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
3
AN: 
152080
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
2
AN XY: 
74284
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41436
American (AMR) 
 AF: 
AC: 
2
AN: 
15250
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5160
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4834
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10616
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
68000
Other (OTH) 
 AF: 
AC: 
0
AN: 
2092
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.592 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Developmental and epileptic encephalopathy    Benign:1 
May 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.